Christine Fox Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

TEVA Quotes by TradingView

Christine Fox is EVP, Head of U.S. Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 58,384 shares of TEVA, which is worth approximately $939,982. The most recent transaction as insider was on Mar 05, 2025, when has been sold 2,147 shares (Ordinary Shares) at a price of $15.91 per share, resulting in proceeds of $34,158. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.4K
32.38% 3M change
n/a 12M change
Total Value Held $939,982

Christine Fox Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2025
SELL
Open market or private sale
$34,158 $15.91 p/Share
2,147 Reduced 3.55%
58,384 Ordinary Shares
Mar 04 2025
SELL
Open market or private sale
$63,454 $15.73 p/Share
4,034 Reduced 6.25%
60,531 Ordinary Shares
Mar 04 2025
BUY
Exercise of conversion of derivative security
-
20,461 Added 24.06%
64,565 Ordinary Shares
Nov 20 2024
SELL
Open market or private sale
$327,075 $16.87 p/Share
19,388 Reduced 30.54%
44,104 Ordinary Shares
Nov 20 2024
BUY
Exercise of conversion of derivative security
-
63,492 Added 50.0%
63,492 Ordinary Shares
CF

Christine Fox

EVP, Head of U.S. Commercial
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TEVA